Skip to main content
    Back to BlogLegal Education
    Published:

    위험한 약물 소송 <<<테>>> FDA이 리콜되고 안전 경고가 약물로 인한 피해를 지적하는 경우 부상당한 환자는 소송을 제기할 근거가 있을 수 있습니다. 리콜과 소송이 어떻게 연결되는지는 다음과 같습니다. <<<포스트>>> 의약품 피해 소송 <<<테>>> 약물 상해 사건에서 어떤 종류의 손해를 복구할 수 있나요? 이 글에서는 제약소송에서의 경제적, 비경제적 보상에 대해 설명합니다. <<<포스트>>> nec 소송 <<<테>>> __B2__ 소송 개요: 소송을 제기할 수 있는 사람, 주장하는 내용, 소송 진행 방법. __B3__ 및 FDA 뒤에 숨은 과학에 대해서는 별도 페이지를 참조하세요. <<<포스트>>> __B2__ 및 FDA <<<테>>> __B3__ 노출과 nec 사이의 연관성에 대한 연구 결과는 무엇입니까? 소송 개요는 __B4__ 소송 페이지를 참조하세요.

    6 min read

    위험한 약물 소송
<<<테>>>
FDA이 리콜되고 안전 경고가 약물로 인한 피해를 지적하는 경우 부상당한 환자는 소송을 제기할 근거가 있을 수 있습니다. 리콜과 소송이 어떻게 연결되는지는 다음과 같습니다.
<<<포스트>>>
의약품 피해 소송
<<<테>>>
약물 상해 사건에서 어떤 종류의 손해를 복구할 수 있나요? 이 글에서는 제약소송에서의 경제적, 비경제적 보상에 대해 설명합니다.
<<<포스트>>>
nec 소송
<<<테>>>
__B2__ 소송 개요: 소송을 제기할 수 있는 사람, 주장하는 내용, 소송 진행 방법. __B3__ 및 FDA 뒤에 숨은 과학에 대해서는 별도 페이지를 참조하세요.
<<<포스트>>>
__B2__ 및 FDA
<<<테>>>
__B3__ 노출과 nec 사이의 연관성에 대한 연구 결과는 무엇입니까? 소송 개요는 __B4__ 소송 페이지를 참조하세요.

    When a drug causes widespread harm that wasn't adequately disclosed, injured people may pursue dangerous drug lawsuits. This article explains how these cases work and how they differ from single-plaintiff claims.

    When the FDA issues a recall or adds a black-box warning to a drug, it often reflects emerging evidence of serious risks. For people who were already harmed by that medication, such regulatory action can support a lawsuit against the manufacturer.

    This page focuses on how FDA recalls, safety alerts, and label changes relate to dangerous-drug litigation—not on general injury compensation (for that, see pharmaceutical injury lawsuits).

    How Recalls and Warnings Affect Lawsuits

    Class I and II recalls: The FDA classifies recalls by severity. Class I (reasonable probability of serious harm or death) and Class II (may cause temporary or reversible harm) can support claims that the product was defective or that warnings were inadequate at the time you used it.

    According to the U.S. Judicial Panel on Multidistrict Litigation, more than 600,000 civil actions have been centralized in MDL proceedings since the program began in 1968.

    The American Bar Association reports that contingency fees in personal injury and mass tort matters commonly range from 33% to 40% of recovery, depending on whether a case settles pre-trial or goes to verdict.

    Label changes and black-box warnings: When the FDA requires new warnings—especially a black-box warning—plaintiffs often argue that the manufacturer knew or should have known of the risk earlier and failed to warn. Evidence from FDA proceedings may be used in court.

    The American Bar Association reports that contingency fees in personal injury and mass tort matters commonly range from 33% to 40% of recovery, depending on whether a case settles pre-trial or goes to verdict.

    Voluntary withdrawals: If a company pulls a drug from the market, that does not automatically prove liability, but it can be part of the picture when arguing that the drug was unreasonably dangerous or that the company failed to warn.

    Top Tier Legal connects you with experienced mass tort attorneys.

    Free, no-obligation case review. Find out if you qualify.

    Get a free case evaluation

    What You Need for a Claim

    A recall or warning alone is not enough. You typically need:

    • Use of the drug during the relevant time (often before the label change or recall).
    • A diagnosed injury or condition that your doctor or experts link to the drug.
    • Compliance with your state’s statute of limitations (see a lawyer for the exact deadline).

    A free case review can help you understand whether your situation fits a dangerous-drug claim and whether a firm in our network may be able to help.

    Recalls vs. Litigation: Key Points

    | Topic | Summary | |-------|---------| | Recalls | FDA or company action to remove or restrict a product; can support but do not replace a legal claim. | | Lawsuits | Individual claims for compensation; require proof of use, injury, and (often) failure to warn or defect. | | Timing | File before your state’s deadline; earlier consultation helps preserve evidence. |

    Federal Judicial Center research notes that MDLs can involve thousands of individual plaintiffs while still preserving separate claims—unlike many class actions where one outcome binds the group.

    According to the RAND Institute for Civil Justice, aggregate tort costs in the United States have exceeded $100 billion in recent benchmark years when insurance and self-insured corporate payouts are combined.

    According to the U.S. Judicial Panel on Multidistrict Litigation, more than 600,000 civil actions have been centralized in MDL proceedings since the program began in 1968.

    Free, no-obligation case review. Find out if you qualify.

    Confidential evaluation at no cost. See if you have options.

    Check your eligibility

    For more on compensation in medication-injury cases, see pharmaceutical injury lawsuits. For Depo-Provera–related claims, see Depo-Provera lawsuit information.

    Top Tier Legal, LLC is not a law firm and does not provide legal advice. This content is for informational purposes only. Submitting information does not create an attorney-client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm. Past results do not guarantee future outcomes.

    Related practice areas

    Time May Be Limited

    Legal deadlines can affect your ability to file a claim. Don't wait—speak with an attorney about a free case evaluation today.

    See If You Qualify